AU2006323040A1 - Trioxane dimers having high anticancer and long-lasting antimalarial activities - Google Patents

Trioxane dimers having high anticancer and long-lasting antimalarial activities Download PDF

Info

Publication number
AU2006323040A1
AU2006323040A1 AU2006323040A AU2006323040A AU2006323040A1 AU 2006323040 A1 AU2006323040 A1 AU 2006323040A1 AU 2006323040 A AU2006323040 A AU 2006323040A AU 2006323040 A AU2006323040 A AU 2006323040A AU 2006323040 A1 AU2006323040 A1 AU 2006323040A1
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
compound
mmol
mhz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006323040A
Other languages
English (en)
Inventor
Astrid C. Baege
Kristina Borstnik
Wonsuk Chang
John Gaetano D'angelo
Lindsey Catherine Hess
Alvin Soloman Kalinda
William Anthony Maio
Seongho Oh
Ikhyeon Paik
Gary H. Posner
Andrew Scott Rosenthal
Sandra Sinishtaj
Aimee R. Usera
Lauren Elaine Woodard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
United States Department of Health and Human Services
Original Assignee
Johns Hopkins University
United States Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, United States Department of Health and Human Services filed Critical Johns Hopkins University
Publication of AU2006323040A1 publication Critical patent/AU2006323040A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2006323040A 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities Abandoned AU2006323040A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US74854805P 2005-12-08 2005-12-08
US60/748,548 2005-12-08
US76512506P 2006-02-03 2006-02-03
US60/765,125 2006-02-03
US79481106P 2006-04-25 2006-04-25
US60/794,811 2006-04-25
PCT/US2006/044845 WO2007067333A2 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Publications (1)

Publication Number Publication Date
AU2006323040A1 true AU2006323040A1 (en) 2007-06-14

Family

ID=38123365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006323040A Abandoned AU2006323040A1 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Country Status (10)

Country Link
US (1) US20090291923A1 (enExample)
EP (1) EP1962596A4 (enExample)
JP (1) JP2009518397A (enExample)
KR (1) KR20080081310A (enExample)
AU (1) AU2006323040A1 (enExample)
BR (1) BRPI0619759A2 (enExample)
CA (1) CA2632200A1 (enExample)
IL (1) IL191597A0 (enExample)
MX (1) MX2008007358A (enExample)
WO (1) WO2007067333A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
US8592611B2 (en) 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010032165A2 (en) * 2008-09-19 2010-03-25 North-West University Prodrugs of artemisinin
US8884032B2 (en) 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
IN2012DN05028A (enExample) 2009-12-07 2015-10-23 Univ Johns Hopkins
CA2782110A1 (en) * 2009-12-07 2011-06-16 Johns Hopkins University N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
US9493480B2 (en) 2011-04-15 2016-11-15 The Johns Hopkins University Monomeric trioxane amide sulfur compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121749A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev 2,3-dioxabicycloÚ3.3.1¾nonane derivatives and antimalarial pharmaceutical compositions comprising them
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US20050240034A1 (en) * 2002-05-07 2005-10-27 Mitchell Avery Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
US7417156B2 (en) * 2002-09-27 2008-08-26 Johns Hopkins University Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers

Also Published As

Publication number Publication date
EP1962596A2 (en) 2008-09-03
WO2007067333A3 (en) 2008-01-31
KR20080081310A (ko) 2008-09-09
JP2009518397A (ja) 2009-05-07
BRPI0619759A2 (pt) 2011-10-18
US20090291923A1 (en) 2009-11-26
EP1962596A4 (en) 2010-09-22
CA2632200A1 (en) 2007-06-14
WO2007067333A2 (en) 2007-06-14
IL191597A0 (en) 2009-02-11
MX2008007358A (es) 2008-11-10

Similar Documents

Publication Publication Date Title
JP7850663B2 (ja) スピロ環含有キナゾリン化合物
AU2011319685B2 (en) Pochoxime conjugates useful for the treatment of HSP90 related pathologies
US20130005696A1 (en) Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof
CA3096790A1 (en) Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates
CN103570792B (zh) 蟾毒灵衍生物、其制备方法、药物组合物及用途
EA019749B1 (ru) Противовирусные соединения
JP2015504075A (ja) ７−置換ハンファンギチンｂ誘導体、その調製方法及び使用
US20250195475A1 (en) Cdk2 inhibitor and preparation method and use thereof
CA3082499A1 (en) Quinazolinone compound and application thereof
EP1962596A2 (en) Trioxane dimers having high anticancer and long-lasting antimalarial activities
KR20180073517A (ko) 트리프톨리드의 c14-히드록실 에스테르화 아미노산 유도체, 및 그의 제조 방법 및 용도
CN112125914B (zh) 5-取代的小檗胺衍生物，其制备方法和应用
US7776849B2 (en) Benzenoid ansamycin derivative
WO1999031084A1 (en) Brefeldin a derivatives
EP2746286A1 (en) Aminated derivative of homoharringtonine, preparation method therefor, and application thereof
CN101325874A (zh) 具有高抗癌活性和长效抗疟活性的三噁烷二聚物
RU2686675C9 (ru) Таксановые соединения, а также способ их получения и их применения
EP2474550A1 (en) Derivatives of Englerin for the treatment of cancer
EP3411377A1 (en) Prodrugs of anticancer agents indotecan and indimitecan
CA2938971A1 (en) Aza-epoxy-guaiane derivatives and treatment of cancer
EP4289481B1 (en) Method of synthesizing (3s,3ar,5r,7as,8s)- hexahydro-4h-3,5-methanofuro[2,3-b]pyran-8-ol
EP2328579B1 (en) Trioxane dimer sulfur compounds
DK2765133T3 (en) An acylated derivative of homoharringtonine, process for the preparation thereof and use thereof
KR101438101B1 (ko) 신규한 플루오로-호모네프라노신 ａ 및 뉴클레오사이드 유도체 및 이의 제조방법, 및 이를 유효성분으로 포함하는 항암제
US20040266753A1 (en) Benzo[a]pyrano[3,2-h]acridin-7-one compounds

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application